Research and Development
UK biotech Pulmocide secures $30m for inhalable lung disease therapies
March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus
Top Ten most popular articles on Pharmafile.com this week
March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Biogen swoops to appoint Ex-Roche Vice President
March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen
The rising threat of antibiotic resistance
March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance
Decade lifespan difference in Americans and Canadians with cystic fibrosis
March 15, 2017 Research and Development Canada, United States, cystic fibrosis
NICE recommends against Opdivo for classical Hodgkin lymphoma
March 15, 2017 Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo
FDA-approved preterm birth drug has no benefit and may cause harm, study suggests
March 15, 2017 Research and Development FDA, Makena
MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma
March 15, 2017 Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda
Patients in UK to be given early access to Sanofi’s eczema treatment
March 14, 2017 Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi
Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer
March 14, 2017 Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR
One in five women with breast cancer could benefit from existing therapy
March 14, 2017 Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors
XTuit Pharmaceuticals move to appoint biotech veteran as CEO
March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals
Immunotherapy: The three major treatments that are changing cancer prognoses
March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq
Combination immunotherapy shows promise in castration-resistant prostate cancer
March 13, 2017 Research and Development, Sales and Marketing prostate cancer
TiGenix announces success of novel heart attack stem cell trial
March 13, 2017 Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack
